Quick Answer
MADRIGAL PHARMACEUTICALS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $958.40 million for the year ending 2025.
- MADRIGAL PHARMACEUTICALS, INC. showed an increase of +432.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from MADRIGAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $958.40 million | Fiscal year 2024: $180.13 million | Fiscal year 2023: $0.00 | Fiscal year 2022: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: